Defunct Company
Total Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
3,031
NCT00134342
Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations
Phase: N/A
Role: Collaborator
Start: Jan 31, 2005
Completion: Apr 30, 2005
NCT02382211
T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays
Role: Lead Sponsor
Start: Jan 31, 2015
Completion: Sep 30, 2017
NCT02470208
Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation
Start: Jun 30, 2015
Completion: Jul 31, 2017
NCT03201042
Lyme Test Indication Combinations (LyTIC) Study
Start: Jun 8, 2017
Completion: Nov 30, 2018
NCT03570411
Evaluating the Clinical Utility of the T-SPOT.CMV Assay for the Prediction of CMV Reactivation Among Pediatric Patients Undergoing Hematopoietic Cell Transplant
Start: Jul 16, 2018
Completion: Apr 22, 2019
NCT03929705
Assessing the Ability of the T-SPOT®.TB Test
Start: May 2, 2019
Completion: Jan 23, 2020
NCT03973970
Assessing the Ability of the T-SPOT®.TB Test (IQ)
Start: Sep 23, 2019
Completion: Jun 30, 2020
NCT04141982
Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)
Start: Nov 4, 2019
Completion: Mar 18, 2020